# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 61-70 of 516 results.
Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma
Status: Available
Last Changed: Feb 20, 2020
First Received: Jun 21, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Olaratumab
Locations: Ironwood Cancer & Research Centers, Glendale, Arizona, United States
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
Kaiser Permanente West Los Angeles, Los Angeles, California, United States
Kaiser Permanente Moreno Valley, Moreno Valley, California, United States
University of Colorado Health Hospital, Aurora, Colorado, United States
... and 69 other locations.
Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
Status: Recruiting
Last Changed: Jan 11, 2019
First Received: Jul 27, 2018
Disease(s): Soft-tissue Sarcoma
Intervention(s): Compound 451238
Locations: The Royal Marsden NHS Foundation Trust, London, United Kingdom
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion
Status: Recruiting
Last Changed: Jan 10, 2020
First Received: Jan 06, 2020
Disease(s): Sarcoma,Soft Tissue
Intervention(s): Proton radiation, Carbon Ion radiation
Locations: University Hospital of Heidelberg, Radiation Oncology, Heidelberg, Germany
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Status: Not yet recruiting
Last Changed: Nov 21, 2019
First Received: Nov 21, 2019
Disease(s): Sarcoma,Soft Tissue
Intervention(s): anlotinib and toripalimab
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
Status: Recruiting
Last Changed: Dec 09, 2019
First Received: Mar 13, 2017
Disease(s): Recurrent Kaposi Sarcoma, Skin Kaposi Sarcoma
Intervention(s): Laboratory Biomarker Analysis, Nelfinavir Mesylate
Locations: UCLA Clinical AIDS Research and Education (CARE) Center, Los Angeles, California, United States
University of Miami, Miami, Florida, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
... and 8 other locations.
Advanced MR Imaging in Sarcoma Patients
Status: Recruiting
Last Changed: Oct 18, 2019
First Received: Mar 10, 2016
Disease(s): Sarcoma
Locations: Mayo Clinic, Rochester, Minnesota, United States
Anlotinib Hydrochloride for Soft Tissue Sarcoma Patients.
Status: Recruiting
Last Changed: Sep 24, 2019
First Received: Mar 26, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Anlotinib Hydrochloride
Locations: Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Ipilimumab +Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Oct 21, 2019
First Received: Oct 08, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Ipilimumab, Cryoablation, Nivolumab
Locations: Stanford Medical Center, Stanford, California, United States
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma
Status: Recruiting
Last Changed: May 21, 2019
First Received: May 15, 2018
Disease(s): Soft Tissue Sarcoma
Intervention(s): Nab-Paclitaxel, gemcitabine
Locations: Universitaetsspital Basel, Basel, Switzerland
Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
Inselspital, Bern, Bern, Switzerland
Kantonsspital Graubünden, Chur, Switzerland
Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland
... and 4 other locations.
Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: Aug 14, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Doxil, Doxorubicin
Locations: Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States